Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Adaptation for Digital Health Technology Assessment Framework in Spain

On November 13, 2023, the Agency for Health Quality and Assessment of Catalonia (AQuAS) released a user guide on the health technology assessment framework: adaptation for digital health technology (DHT) assessment. This methodological framework describes 13 domains, 41 dimensions, 9 subdimensions, and 21 levels of evidence that should be considered in the evaluation of DHT. It aims to facilitate the evaluation process of DHT and, consequently, the identification of the value of a particular digital technology to inform decision-making. The guidelines described can be equally useful for HTA agencies, researchers, and developers of DHT, decision-makers, and regulators.

The full details in Spanish can be found here.

This news is just one of about 300 market access news collected by our team in the subscription service Market Access Monitor every week from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.